Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology-Reference-Cited by-同舟云学术

Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Published:2020-08 Issue:8 Volume:18 Page:1105-1123
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Davies Kimberly¹,Barth Matthew²,Armenian Saro³,Audino Anthony N.⁴,Barnette Phillip⁵,Cuglievan Branko⁶,Ding Hilda⁷,Ford James B.⁸,Galardy Paul J.⁹,Gardner Rebecca¹⁰,Hanna Rabi¹¹,Hayashi Robert¹²,Kovach Alexandra E.¹³,Machnitz Andrea Judit¹⁴,Maloney Kelly W.¹⁵,Marks Lianna¹⁶,Page Kristin¹⁷,Reilly Anne F.¹⁸,Weinstein Joanna L.¹⁹,Xavier Ana C.²⁰,McMillian Nicole R.²¹,Freedman-Cass Deborah A.²¹

Affiliation:

1. 1Dana-Farber/Boston Children's Cancer and Blood Disorders Center;

2. 2Roswell Park Comprehensive Cancer Center;

3. 3City of Hope National Medical Center;

4. 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

5. 5Huntsman Cancer Institute at the University of Utah;

6. 6The University of Texas MD Anderson Cancer Center;

7. 7UCSD Rady Children's Hospital/UC San Diego Moores Cancer Center;

8. 8Fred & Pamela Buffett Cancer Center;

9. 9Mayo Clinic Cancer Center;

10. 10Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

11. 11Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

12. 12Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

13. 13Vanderbilt-Ingram Cancer Center;

14. 14The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

15. 15Children's Hospital of Colorado/University of Colorado Cancer Center;

16. 16Stanford Cancer Institute;

17. 17Duke Cancer Institute;

18. 18Abramson Cancer Center at the University of Pennsylvania;

19. 19Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

20. 20Children's of Alabama/O'Neal Comprehensive Cancer Center at UAB; and

21. 21National Comprehensive Cancer Network

Abstract

Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/18/8/article-p1105.xml

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrin‐associated diffuse large B‐cell lymphoma in a pediatric patient;Pediatric Blood & Cancer;2024-07-02

2. Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement;Frontiers in Immunology;2023-08-21

3. Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review;Frontiers in Immunology;2023-01-17

4. Comparison of Population Characteristics in Real-World Clinical Oncology Databases in the US: Flatiron Health-Foundation Medicine Clinico-Genomic Databases, Flatiron Health Research Databases, and the National Cancer Institute SEER Population-Based Cancer Registry;2023-01-05

5. Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis;Blood Research;2022-03-31